BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30598260)

  • 1. Histone acetyltransferase MOF is involved in suppression of endometrial cancer and maintenance of ERα stability.
    Wu Y; Zeng K; Wang C; Wang S; Sun H; Liu W; Wang X; Niu J; Cong SY; Zhou X; Zhao Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):541-548. PubMed ID: 30598260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma.
    Wei S; Liu W; Sun N; Wu Y; Song H; Wang C; Wang S; Zou R; Lin L; Zeng K; Zhou B; Wang M; Luan R; Yang F; Zhao Y
    Cancer Sci; 2021 May; 112(5):1865-1877. PubMed ID: 33544437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
    Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
    Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression.
    Qi Y; Tan M; Zheng M; Jin S; Wang H; Liu J; Wang P; Nie X; Gao L; Lin B
    Jpn J Clin Oncol; 2020 Mar; 50(3):241-253. PubMed ID: 31990345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
    Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
    Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.
    Lin CY; Chao A; Wang TH; Lee LY; Yang LY; Tsai CL; Wang HS; Lai CH
    Oncotarget; 2016 Sep; 7(37):60038-60052. PubMed ID: 27527851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
    Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
    Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer.
    Yu L; Liang Y; Cao X; Wang X; Gao H; Lin SY; Schiff R; Wang XS; Li K
    Oncogene; 2017 May; 36(20):2910-2918. PubMed ID: 27893709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α.
    Kojima M; Sugimoto K; Kobayashi M; Ichikawa-Tomikawa N; Kashiwagi K; Watanabe T; Soeda S; Fujimori K; Chiba H
    Mol Cancer Res; 2021 Jul; 19(7):1208-1220. PubMed ID: 33727343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of peroxisome proliferator-activated receptor γ inhibits estrogen receptor α transcriptional activity in endometrial carcinoma cells.
    Zhang G; Hou X; Gao S
    Oncol Rep; 2015 Mar; 33(3):1227-34. PubMed ID: 25592200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A20-mediated deubiquitination of ERα in the microenvironment of CD163
    Lv Q; Xie L; Cheng Y; Shi Y; Shan W; Ning C; Xie B; Yang B; Luo X; He Q; Zhu Q; Zhang Y; Zhang Z; Wang C; Chen X; Xu C
    Cancer Lett; 2019 Feb; 442():137-147. PubMed ID: 30420335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetyltransferase Hbo1 destabilizes estrogen receptor α by ubiquitination and modulates proliferation of breast cancers.
    Iizuka M; Susa T; Takahashi Y; Tamamori-Adachi M; Kajitani T; Okinaga H; Fukusato T; Okazaki T
    Cancer Sci; 2013 Dec; 104(12):1647-55. PubMed ID: 24125069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of estrogen receptor coregulators in normal and malignant human endometrium.
    Kershah SM; Desouki MM; Koterba KL; Rowan BG
    Gynecol Oncol; 2004 Jan; 92(1):304-13. PubMed ID: 14751175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.
    Chen Z; Yang HJ; Lin Q; Zhu MJ; Yu YY; He XY; Wan XP
    Cell Commun Signal; 2020 Jun; 18(1):84. PubMed ID: 32503542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
    Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
    Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.
    Kavlashvili T; Jia Y; Dai D; Meng X; Thiel KW; Leslie KK; Yang S
    PLoS One; 2016; 11(2):e0148912. PubMed ID: 26859414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity.
    Stanišić V; Malovannaya A; Qin J; Lonard DM; O'Malley BW
    J Biol Chem; 2009 Jun; 284(24):16135-16145. PubMed ID: 19383985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen.
    Ning C; Xie B; Zhang L; Li C; Shan W; Yang B; Luo X; Gu C; He Q; Jin H; Chen X; Zhang Z; Feng Y
    Cancer Res; 2016 Mar; 76(6):1354-66. PubMed ID: 26744532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
    Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
    Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.